RPA1 and cancer: Additionally, increased levels of RPA in cancer chemotherapy may serve as an adaptive process to protect cells against genotoxic stress, suggesting that having active RPA and a fully functional DDR, cells have a chance to survive DNA damage, e.g., in cancer chemotherapy, whereas when inhibiting both RPA functions and DDR, cancer-treated cells become sentenced to apoptosis or other death pathways.